1. FDADraft guidance for industry: multiplicity endpoints in clinical trials;2017.http://www.fda.gove/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM536750.pdf.
2. Editorial: Multiplicity issues in clinical trials
3. EMAGuideline on multiplicity issues in clinical trials;2017.https://www.ema.europa.eu/en/documents/scientific‐guideline/draft‐guideline‐multiplicity‐issues‐clinical‐trials_en.pdf.
4. Rectangular Confidence Regions for the Means of Multivariate Normal Distributions
5. A simple sequentially rejective multiple test procedure;Holms S;Scandinav J Stat,1979